Evaluation of the combination effects of silodosin and dutasteride in patients with urination disorders associated with benign prostatic hyperplasia

Trial Profile

Evaluation of the combination effects of silodosin and dutasteride in patients with urination disorders associated with benign prostatic hyperplasia

Discontinued
Phase of Trial: Phase II

Latest Information Update: 31 Mar 2017

At a glance

  • Drugs Silodosin (Primary) ; Dutasteride; Tamsulosin
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Sponsors Kissei Pharmaceutical
  • Most Recent Events

    • 29 Mar 2017 Status changed from recruiting to discontinued.
    • 22 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top